Evaluation of the effect of anti-tumor necrosis factor agent use on rheumatoid arthritis work disability: the jury is still out.
about
Non-pharmacological interventions for preventing job loss in workers with inflammatory arthritisNon-pharmacological interventions for improving work participation in patients with inflammatory arthritisCurrent risk factors for work disability associated with rheumatoid arthritis: recent data from a US national cohortWork disability remains a major problem in rheumatoid arthritis in the 2000s: data from 32 countries in the QUEST-RA studyNontuberculous mycobacteria infections and anti-tumor necrosis factor-alpha therapyWorking status in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis: results from the British Society for Rheumatology Biologics Register.Generalized bone loss as a predictor of three-year radiographic damage in African American patients with recent-onset rheumatoid arthritis.Exploring the diversity of conceptualizations of work (dis)ability: a scoping review of published definitions.Effect of TNF antagonists on the productivity of daily work of patients with rheumatoid arthritis.Impact of Adalimumab on Work Productivity and Activity Impairment in Japanese Patients with Rheumatoid Arthritis: Large-Scale, Prospective, Single-Cohort ANOUVEAU Study.Effect of adalimumab on the work-related outcomes scores in patients with early rheumatoid arthritis receiving methotrexate.Prognostic factors for long-term work disability due to musculoskeletal disorders.Costs of rheumatoid arthritis during the period 1990-2010: a register-based cost-of-illness study in Sweden.Experiences and needs for work participation in employees with rheumatoid arthritis treated with anti-tumour necrosis factor therapy.Work instability in rheumatoid arthritis patients from Argentina: prevalence and associated factors.Early rheumatoid arthritis 6 years after diagnosis is still associated with high direct costs and increasing loss of productivity: the Swedish TIRA project.The effect of etanercept on work productivity in patients with early active rheumatoid arthritis: results from the COMET study
P2860
Q24188097-233BDE60-2EFD-4943-914A-CB5060B5895DQ24197632-0A900A2B-A163-4195-8368-8CF8ED626A4CQ33413158-F4571E76-A39C-4DC6-BEEA-4669565C0623Q33540305-5E967F47-4FA4-4C41-9391-31C586CF3606Q33836681-DDF3EC42-CF88-45C1-8E29-548FE08175C6Q33990812-720EA554-17DD-4C0B-AD72-7EA39ED11A9DQ34067290-17B68C3A-AAC6-4F05-A01E-FF1965DD5A50Q34864506-2D8F076F-D6ED-4B2B-9A8C-301E9800E4C9Q36555104-8C5BBEF1-5DFF-4579-A622-5C30E8F37434Q37699707-BBEE51D3-EBB4-461C-BF56-B4FB06C148F1Q39821943-E815540E-F72F-47C9-A150-1D4B41DCB765Q44476316-38EAF833-4117-4BA7-B17A-A504A290C2AFQ44918475-958EA0A9-AC00-48EC-9F64-DA477A7B8786Q50624218-E6A013EC-EC6D-4793-8634-D552BB2127FFQ51132948-D1E83331-DDA3-49DC-8975-7DA1785BF9FEQ54417889-AFC1C75B-AAB4-4556-B199-AAC13A4CA6C9Q58025221-EA9F6D92-AC0F-4123-8C34-9714A9F96F0C
P2860
Evaluation of the effect of anti-tumor necrosis factor agent use on rheumatoid arthritis work disability: the jury is still out.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Evaluation of the effect of an ...... bility: the jury is still out.
@en
type
label
Evaluation of the effect of an ...... bility: the jury is still out.
@en
prefLabel
Evaluation of the effect of an ...... bility: the jury is still out.
@en
P2860
P50
P356
P1476
Evaluation of the effect of an ...... bility: the jury is still out.
@en
P2093
Saralynn Allaire
P2860
P304
P356
10.1002/ART.23923
P577
2008-08-01T00:00:00Z